The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum.
Open accessAbstract
Previous studies have demonstrated the presence of myocardial depression in clinical and experimental septic shock. This depression is associated with the presence of a circulating myocardial depressant substance with physical characteristics consistent with cytokines. The present study utilized an in vitro myocardial cell assay to examine the role of various human recombinant cytokines, including tumor necrosis factor (TNF)alpha and interleukin (IL)1beta, in depression of cardiac myocyte contractile function induced by serum from humans with septic shock. The extent and velocity of electrically paced rat cardiac myocytes in tissue culture was quantified by a closed loop video tracking system. Individually, TNF-alpha and IL-1beta each caused significant concentration-dependent depression of maximum extent and peak velocity of myocyte shortening in vitro. In combination, TNF-alpha and IL-1beta induced depression of myocardial cell contractility at substantially lower concentrations consistent with a synergistic effect. Using immunoabsorption, removal of both TNF-alpha and IL-1beta (but not either alone) from the serum of five patients with acute septic shock and marked reversible myocardial depression resulted in elimination of serum myocardial depressant activity. IL-2, -4, -6, -8, -10, and interferon gamma failed to cause significant cardiac myocyte depression over a wide range of concentrations. These data demonstrate that TNF-alpha and IL-1beta cause depression of myocardial cell contraction in vitro and suggest that these two cytokines act synergistically to cause sepsis-associated myocardial depression in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Negative Inotropic Effects of Cytokines on the Heart Mediated by Nitric Oxide
Finkel, M. S., Oddis, C. V., Jacob, T. D., Watkins, S. C., Hattler, B. G., & Simmons, R. L. (1992) · Science · doi:10.1126/science.1631560 · Cited by 1,628
Profound but Reversible Myocardial Depression in Patients with Septic Shock
PARKER, M. M., SHELHAMER, J. H., BACHARACH, S. L., GREEN, M. V., NATANSON, C., FREDERICK, T. M., DAMSKE, B. A., & PARRILLO, J. E. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-4-483 · Cited by 1,585
Self-citationPathogenetic Mechanisms of Septic Shock
Epstein, F. H., & Parrillo, J. E. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282008 · Cited by 1,548
Self-citationParrillo, J. E., Parker, M. M., Natanson, C., Suffredini, A. F., Danner, R. L., Cunnion, R. E., & Ognibene, F. P. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-3-227 · Cited by 1,179
Self-citationWaage, A., Brandtzaeg, P., Halstensen, A., Kierulf, P., & Espevik, T. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.1.333 · Cited by 1,173
Plasma Cytokine and Endotoxin Levels Correlate with Survival in Patients with the Sepsis Syndrome
Casey, L. C., Balk, R. A., & Bone, R. C. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-8-199310150-00001 · Cited by 1,041
Okusawa, S., Gelfand, J. A., Ikejima, T., Connolly, R. J., & Dinarello, C. A. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113431 · Cited by 983
Tumor Necrosis Factor and Interleuktn-1 in the Serum of Children with Severe Infectious Purpura
Girardin, E., Grau, G. E., Dayer, J.-M., Roux-Lombard, P., the J5 Study Group*, & Lambert, P.-H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198808183190703 · Cited by 737
Yokoyama, T., Vaca, L., Rossen, R. D., Durante, W., Hazarika, P., & Mann, D. L. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116834 · Cited by 717
Endotoxemia in Human Septic Shock
Danner, R. L., Elin, R. J., Hosseini, J. M., Wesley, R. A., Reilly, J. M., & Parillo, J. E. (1991) · Chest · doi:10.1378/chest.99.1.169 · Cited by 656
Cited by
Tumor necrosis factor in the heart
Meldrum, D. R. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.274.3.r577 · Cited by 746
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
Abbate, A., Toldo, S., Marchetti, C., Kron, J., Van Tassell, B. W., & Dinarello, C. A. (2020) · Circulation Research · doi:10.1161/circresaha.120.315937 · Cited by 730
Pathophysiology of sepsis-induced cardiomyopathy
Hollenberg, S. M., & Singer, M. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00492-2 · Cited by 727
Mechanisms of sepsis-induced cardiac dysfunction
Rudiger, A., & Singer, M. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000266683.64081.02 · Cited by 704
The NLRP3 inflammasome in acute myocardial infarction
Toldo, S., & Abbate, A. (2018) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.161 · Cited by 665
Cardiac Failure in Transgenic Mice With Myocardial Expression of Tumor Necrosis Factor-α
Bryant, D., Becker, L., Richardson, J., Shelton, J., Franco, F., Peshock, R., Thompson, M., & Giroir, B. (1998) · Circulation · doi:10.1161/01.cir.97.14.1375 · Cited by 600
Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management
van Deuren, M., Brandtzaeg, P., & van der Meer, J. W. M. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.1.144 · Cited by 588
Sepsis-induced myocardial dysfunction: pathophysiology and management
Kakihana, Y., Ito, T., Nakahara, M., Yamaguchi, K., & Yasuda, T. (2016) · Journal of Intensive Care · doi:10.1186/s40560-016-0148-1 · Cited by 544
Beesley, S. J., Weber, G., Sarge, T., Nikravan, S., Grissom, C. K., Lanspa, M. J., Shahul, S., & Brown, S. M. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000002851 · Cited by 528
Mechanisms of Cardiac and Renal Dysfunction in Patients Dying of Sepsis
Takasu, O., Gaut, J. P., Watanabe, E., To, K., Fagley, R. E., Sato, B., Jarman, S., Efimov, I. R., Janks, D. L., Srivastava, A., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201211-1983oc · Cited by 514
Ruiz-del-Arbol, L., Urman, J., Fernández, J., González, M., Navasa, M., Monescillo, A., Albillos, A., Jiménez, W., & Arroyo, V. (2003) · Hepatology · doi:10.1053/jhep.2003.50447 · Cited by 497
Imtiyaz, H. Z., Williams, E. P., Hickey, M. M., Patel, S. A., Durham, A. C., Yuan, L.-J., Hammond, R., Gimotty, P. A., Keith, B., & Simon, M. C. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39506 · Cited by 461
Tumor necrosis factor-alpha and interleukin-1 beta synergistically depress human myocardial function
Cain, B. S., Meldrum, D. R., Dinarello, C. A., Meng, X., Joo, K. S., Banerjee, A., & Harken, A. H. (1999) · Critical Care Medicine · doi:10.1097/00003246-199907000-00018 · Cited by 421
Inflammatory Cytokines and Chemokines as Therapeutic Targets in Heart Failure
Hanna, A., & Frangogiannis, N. G. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-07071-0 · Cited by 418
The role of the NLRP3 inflammasome and pyroptosis in cardiovascular diseases
Toldo, S., & Abbate, A. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00946-3 · Cited by 411
TNFα in atherosclerosis, myocardial ischemia/reperfusion and heart failure
Kleinbongard, P., Heusch, G., & Schulz, R. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.05.002 · Cited by 409
Hypoxia-Inducible Factors as Essential Regulators of Inflammation
Imtiyaz, H. Z., & Simon, M. C. (2010) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2010_74 · Cited by 379
Cytokine-Induced Modulation of Cardiac Function
Prabhu, S. D. (2004) · Circulation Research · doi:10.1161/01.res.0000150734.79804.92 · Cited by 375
Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes
Ammann, P., Maggiorini, M., Bertel, O., Haenseler, E., Joller-Jemelka, H. I., Oechslin, E., Minder, E. I., Rickli, H., & Fehr, T. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00421-2 · Cited by 372
Role of Platelet-Activating Factor in Cardiovascular Pathophysiology
Montrucchio, G., Alloatti, G., & Camussi, G. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.4.1669 · Cited by 371
Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock
Pathan, N., Hemingway, C. A., Alizadeh, A. A., Stephens, A. C., Boldrick, J. C., Oragui, E. E., McCabe, C., Welch, S. B., Whitney, A., O'Gara, P., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(03)15326-3 · Cited by 362
Martin, L., Derwall, M., Al Zoubi, S., Zechendorf, E., Reuter, D. A., Thiemermann, C., & Schuerholz, T. (2019) · Chest · doi:10.1016/j.chest.2018.08.1037 · Cited by 360
The Association between Pneumococcal Pneumonia and Acute Cardiac Events
Musher, D. M., Rueda, A. M., Kaka, A. S., & Mapara, S. M. (2007) · Clinical Infectious Diseases · doi:10.1086/518849 · Cited by 352
Lipid Use and Misuse by the Heart
Schulze, P. C., Drosatos, K., & Goldberg, I. J. (2016) · Circulation Research · doi:10.1161/circresaha.116.306842 · Cited by 352
Atri, D., Siddiqi, H. K., Lang, J. P., Nauffal, V., Morrow, D. A., & Bohula, E. A. (2020) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2020.04.002 · Cited by 321
Human malarial disease: a consequence of inflammatory cytokine release
Clark, I. A., Budd, A. C., Alleva, L. M., & Cowden, W. B. (2006) · Malaria Journal · doi:10.1186/1475-2875-5-85 · Cited by 317
The role of IL-1 in the pathogenesis of heart disease
Bujak, M., & Frangogiannis, N. G. (2009) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-009-0024-y · Cited by 307
Sepsis-Associated Myocardial Dysfunction
Maeder, M., Fehr, T., Rickli, H., & Ammann, P. (2006) · Chest · doi:10.1378/chest.129.5.1349 · Cited by 310
Pomerantz, B. J., Reznikov, L. L., Harken, A. H., & Dinarello, C. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041611398 · Cited by 310
A review of sepsis-induced cardiomyopathy
Sato, R., & Nasu, M. (2015) · Journal of Intensive Care · doi:10.1186/s40560-015-0112-5 · Cited by 306
Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression
Morelli, A., De Castro, S., Teboul, J.-L., Singer, M., Rocco, M., Conti, G., De Luca, L., Di Angelantonio, E., Orecchioni, A., Pandian, N. G., et al. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2619-z · Cited by 303
Targeting Interleukin-1 in Heart Disease
Van Tassell, B. W., Toldo, S., Mezzaroma, E., & Abbate, A. (2013) · Circulation · doi:10.1161/circulationaha.113.003199 · Cited by 302
J. Romero-Bermejo, F., Ruiz-Bailen, M., Gil-Cebrian, J., & J. Huertos-Ranchal, M. (2011) · Current Cardiology Reviews · doi:10.2174/157340311798220494 · Cited by 287
Role of Inflammation in Heart Failure
Shirazi, L. F., Bissett, J., Romeo, F., & Mehta, J. L. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0660-3 · Cited by 278
Molecular basis of endothelial dysfunction in sepsis
Peters, K. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00397-3 · Cited by 268
Interleukin-6 and Cardiovascular Diseases
Kanda, T., & Takahashi, T. (2004) · Japanese Heart Journal · doi:10.1536/jhj.45.183 · Cited by 265
Vasopressor and inotropic support in septic shock: An evidence-based review
Beale, R. J., Hollenberg, S. M., Vincent, J.-L., & Parrillo, J. E. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000142909.86238.b1 · Cited by 260
Self-citationOxidative stress in sepsis: Pathophysiological implications justifying antioxidant co-therapy
Prauchner, C. A. (2017) · Burns · doi:10.1016/j.burns.2016.09.023 · Cited by 256
Severe sepsis and septic shock in the elderly: An overview
Juneja, D. (2012) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v1.i1.23 · Cited by 255
Astiz, M. E., & Rackow, E. C. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01134-9 · Cited by 255
Greulich, S., Maxhera, B., Vandenplas, G., de Wiza, D. H., Smiris, K., Mueller, H., Heinrichs, J., Blumensatt, M., Cuvelier, C., Akhyari, P., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.039586 · Cited by 210
Mechanisms of Cardiovascular Toxicities Associated With Immunotherapies
Baik, A. H., Oluwole, O. O., Johnson, D. B., Shah, N., Salem, J.-E., Tsai, K. K., & Moslehi, J. J. (2021) · Circulation Research · doi:10.1161/circresaha.120.315894 · Cited by 138
Escames, G., Acuña-Castroviejo, D., López, L. C., Tan, D.-X., Maldonado, M. D., Sánchez-Hidalgo, M., León, J., & Reiter, R. J. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.9.0001 · Cited by 118
Myocarditis: An Interleukin-1-Mediated Disease?
De Luca, G., Cavalli, G., Campochiaro, C., Tresoldi, M., & Dagna, L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01335 · Cited by 79
“This role of IL-1 as a cardiodepressant factor is also described in sepsis (54).”
BackgroundShort- and long-term effects of IL-1 and TNF antagonists on periodontal wound healing
Zhang, X., Kohli, M., Zhou, Q., Graves, D. T., & Amar, S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3514 · Cited by 71
sGCα1β1attenuates cardiac dysfunction and mortality in murine inflammatory shock models
Buys, E. S., Cauwels, A., Raher, M. J., Passeri, J. J., Hobai, I., Cawley, S. M., Rauwerdink, K. M., Thibault, H., Sips, P. Y., Thoonen, R., et al. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00367.2009 · Cited by 49
Metadata
- Authors
- Kumar, A., Thota, V, Dee, L., Olson, J., Uretz, E., & Parrillo, J. E.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1996-03-01
- Volume
- 183
- Issue
- 3
- Pages
- 949-958
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2161089523
- Cited by
- 791
- References
- 32
- FWCI
- 18.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.